R.PR
REGISTERED-PRINCIPAL REGISTER
01/18/2022
Back to search
Official data from USPTO
ABSOLUTE Q
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ABSOLUTE Q
ST13
US500000088921994Class
9, 10
Filing
88921994
Registration
6623295
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
01/18/2022
Trademark type
Word
Nice classes
9, 10
Filing date
05/18/2020
Registration date
01/18/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/18/2022
Last transaction
01/18/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2020-12-00
First use in commerce
2020-12-00
Drawing code
4
Owner type
03
Owner location
Palo Alto, CA
Examiner
MIZELLE HOWARD, DEZMONA
Law office
M10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
C. I. (pessoa física)
Representatives
Kenya L. Williams Thermo Fisher Scientific
Technical classification
Nice Classes
Class 9Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Polymerase chain reaction (PCR) instruments for use in scientific researchlaboratory apparatus and instruments for amplifying DNA using polymerase chain reaction (PCR); scientific research instruments for use in measuring and quantifying copy number of DNA
Class 10
Medical devices for detection of cancer; medical devices for detection of infectious diseasedigital polymerase chain reaction (PCR) platform; medical devices for use in pre-natal screeningsdigital polymerase chain reaction (PCR) platform; medical devicespolymerase chain reaction (PCR) instruments for use in detectingdiagnosing and treating cancer and infectious diseasedigital polymerase chain reaction (PCR) platform; medical devicespolymerase chain reaction (PCR) instruments for use in pre-natal screeningsdigital polymerase chain reaction (PCR) platform; medical devicesinstruments for use in measuring and quantifying copy number of DNA for medical diagnostic purposesdigital polymerase chain reaction (PCR) platform
Publications
History of USPTO decisions and trademark events.
26 publications found
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
12/15/2021
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
12/14/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/30/2021
SUPC
STATEMENT OF USE PROCESSING COMPLETE
11/29/2021
EX2G
SOU EXTENSION 2 GRANTED
11/29/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
11/29/2021
IUAF
USE AMENDMENT FILED
11/18/2021
EXT2
SOU EXTENSION 2 FILED
11/18/2021
EEXT
SOU TEAS EXTENSION RECEIVED
11/18/2021
EISU
TEAS STATEMENT OF USE RECEIVED
11/18/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/17/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/17/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/17/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/19/2021
EX1G
SOU EXTENSION 1 GRANTED
05/17/2021
EXT1
SOU EXTENSION 1 FILED
05/17/2021
EEXT
SOU TEAS EXTENSION RECEIVED
05/17/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
11/24/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/29/2020
PUBO
PUBLISHED FOR OPPOSITION
09/29/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/09/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/24/2020
DOCK
ASSIGNED TO EXAMINER
08/15/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/03/2020
NWAP
NEW APPLICATION ENTERED
05/21/2020
Continuous trademark protection
Get notified about every new filing that threatens ABSOLUTE Q or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.